Westfuller Advisors’s DexCom DXCM Stock Holding History

Westfuller Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-23	Closed	-$1.57K	–	784
2025 Q3	$1.57K	Buy	+23	New	+$1.82K	﹤0.01%	667

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Westfuller Advisors's DXCM Position: Q4 2025 in Review

Westfuller Advisors sold out of DexCom (DXCM) in Q4 2025, closing a stake of 23 shares — an estimated $1.57K sold.

Westfuller Advisors first reported a position in DXCM in Q3 2025 and held it in 1 quarter. The position peaked at $1.57K in Q3 2025. 921 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Westfuller Advisors reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Westfuller Advisors sold 23 DexCom shares in Q4 2025, an estimated $1.57K.
Westfuller Advisors first reported a position in DexCom in Q3 2025 and held it in 1 quarter.
Westfuller Advisors's DexCom position peaked at $1.57K in Q3 2025.
921 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Westfuller Advisors's 13F filing for Q4 2025, filed 21 Jan 2026.